MULTIFESTO.
THE PROBLEM
Half the world’s adult population has metabolic syndrome or its downstream conditions
![](https://multiomic.health/wp-content/uploads/2022/04/MetSyn-Web-2-1024x669.png)
Quite likely either you or someone you know has metabolic syndrome or its downstream conditions...
Current treatments are imprecise "one-size-fits-all" medicines
A PILOT FOR PRECISION MEDICINE IN METABOLIC SYNDROME
Success of cancer precision medicines indicates what’s possible in metabolic syndrome-conditions
![](https://multiomic.health/wp-content/uploads/2022/04/genomic-analysis-1406x1536.png)
PRECISION THERAPEUTICS FOCUS THE RIGHT TREATMENT ON THE RIGHT PATIENT
![](https://multiomic.health/wp-content/uploads/2022/04/CANCER-1.png)
![](https://multiomic.health/wp-content/uploads/2022/04/bubbles.png)
The Market Potential
The oncology drugs market has grown from $10 billion in 2000 to over $140 billion in 2019
Estimated world metabolic syndrome drug market in 2040 after precision revolution is >$1.6 trillion
THE NEED FOR MULTIPLE OMICS
Metabolic syndrome-related conditions are multifactorial, requiring more complex data to unravel
![](https://multiomic.health/wp-content/uploads/2022/07/Screen-Shot-2022-07-08-at-16.04.38.png)
METABOLIC SYNDROME DISEASE ORIGIN AND PROGRESSION ARE INFLUENCED BY MANY FACTORS BESIDES THE GENOME AND ALSO THEIR UNIQUE INTERACTIONS WITH ONE ANOTHER
WHAT WE ARE BUILDING
THE MOHSAIC® PLATFORM
1
MultiOmic’s process begins with the collection of biological samples along with clinical and outcome data
2
Multi-omics data is derived from these samples
3
Raw data from the vendors is pooled into a central data lake
4
The data lake is used to build artificial intelligence (AI)-enabled computational system biology models that are fine-tuned with wet lab experimentation
5
The model is utilized to identify endotypes, causal pathways and precision therapeutics
![](https://multiomic.health/wp-content/uploads/2022/04/Nature-Fig.2-MOHSAIC-Final-website-5-914x1024.png)
WHY NOW
A PERFECT STORM—IN THE POSITIVE SENSE—IS FORMING FOR METABOLIC SYNDROME THERAPEUTICS
![](https://multiomic.health/wp-content/uploads/2022/04/Slide-6-1024x858.png)
Data-DRIVEN THERAPEUTICS FOR WORLD'S #1 HEALTH PROBLEM
![](https://multiomic.health/wp-content/uploads/2022/04/Flow-Diagram.png)
Contact.
Want to be a part of our team?
Got a partnership in mind?
Get in touch with us and know more about how we are changing the face of healthcare.
THE COMPANY
Multiomic Health Limited is a registered UK company
Company #13246608
EMAIL US
info@multiomic.health
Connect